706-3SBio
- Generic Name
- 706-3SBio
Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Target Recruit Count
- 60
- Registration Number
- NCT06533605
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath